146 related articles for article (PubMed ID: 20038731)
21. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Tien FM; Yao CY; Tsai XC; Lo MY; Chen CY; Lee WH; Lin CC; Kuo YY; Peng YL; Tseng MH; Wu YS; Liu MC; Lin LI; Chuang MK; Ko BS; Yao M; Tang JL; Chou WC; Hou HA; Tien HF
Blood Cancer J; 2024 Jan; 14(1):15. PubMed ID: 38253683
[TBL] [Abstract][Full Text] [Related]
22. Association between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese population.
Qi XW; Zheng XD; Zong BG; Chen QQ; Zhang F; Yang XH; Zhang Y; Liu JL; Jiang J
Am J Cancer Res; 2015; 5(3):1234-50. PubMed ID: 26046002
[TBL] [Abstract][Full Text] [Related]
23. Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
Archer KJ; Fu H; Mrózek K; Nicolet D; Mims AS; Uy GL; Stock W; Byrd JC; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T; Eisfeld AK
J Hematol Oncol; 2024 May; 17(1):28. PubMed ID: 38702786
[TBL] [Abstract][Full Text] [Related]
24. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.
Bhatnagar B; Kohlschmidt J; Mrózek K; Zhao Q; Fisher JL; Nicolet D; Walker CJ; Mims AS; Oakes C; Giacopelli B; Orwick S; Boateng I; Blachly JS; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Stone RM; Byrd JC; Paskett ED; de la Chapelle A; Garzon R; Eisfeld AK
Cancer Discov; 2021 Mar; 11(3):626-637. PubMed ID: 33277314
[TBL] [Abstract][Full Text] [Related]
25. Identification of Novel Functional Variants of SIN3A and SRSF1 among Somatic Variants in Acute Myeloid Leukemia Patients.
Min JW; Koh Y; Kim DY; Kim HL; Han JA; Jung YJ; Yoon SS; Choi SS
Mol Cells; 2018 May; 41(5):465-475. PubMed ID: 29764005
[TBL] [Abstract][Full Text] [Related]
26. GATA2 mutant variant allele frequency may reflect prognosis in Chinese adult patients with de novo cytogenetically normal acute myeloid leukemia.
Ren H; Hong M; Feng J; Hao Z; Chen X; Liang F; Wei W; Liang X; Wang H; Chen X
Biomol Biomed; 2024 Feb; ():. PubMed ID: 38416121
[TBL] [Abstract][Full Text] [Related]
27. Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patients.
Wang YH; Orgueira AM; Lin CC; Yao CY; Lo MY; Tsai CH; de la Fuente Burguera A; Hou HA; Chou WC; Tien HF
Sci Rep; 2024 May; 14(1):11064. PubMed ID: 38744924
[TBL] [Abstract][Full Text] [Related]
28. Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Iacobucci I; Wen J; Meggendorfer M; Choi JK; Shi L; Pounds SB; Carmichael CL; Masih KE; Morris SM; Lindsley RC; Janke LJ; Alexander TB; Song G; Qu C; Li Y; Payne-Turner D; Tomizawa D; Kiyokawa N; Valentine M; Valentine V; Basso G; Locatelli F; Enemark EJ; Kham SKY; Yeoh AEJ; Ma X; Zhou X; Sioson E; Rusch M; Ries RE; Stieglitz E; Hunger SP; Wei AH; To LB; Lewis ID; D'Andrea RJ; Kile BT; Brown AL; Scott HS; Hahn CN; Marlton P; Pei D; Cheng C; Loh ML; Ebert BL; Meshinchi S; Haferlach T; Mullighan CG
Nat Genet; 2019 Apr; 51(4):694-704. PubMed ID: 30926971
[TBL] [Abstract][Full Text] [Related]
29. High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
Loriaux MM; Levine RL; Tyner JW; Fröhling S; Scholl C; Stoffregen EP; Wernig G; Erickson H; Eide CA; Berger R; Bernard OA; Griffin JD; Stone RM; Lee B; Meyerson M; Heinrich MC; Deininger MW; Gilliland DG; Druker BJ
Blood; 2008 May; 111(9):4788-96. PubMed ID: 18252861
[TBL] [Abstract][Full Text] [Related]
30. Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
Song H; Liu Y; Tan Y; Zhang Y; Jin W; Chen L; Wu S; Yan J; Li J; Chen Z; Chen S; Wang K
Blood; 2022 Sep; 140(10):1132-1144. PubMed ID: 35653587
[TBL] [Abstract][Full Text] [Related]
31. Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression.
Yun H; Narayan N; Vohra S; Giotopoulos G; Mupo A; Madrigal P; Sasca D; Lara-Astiaso D; Horton SJ; Agrawal-Singh S; Meduri E; Basheer F; Marando L; Gozdecka M; Dovey OM; Castillo-Venzor A; Wang X; Gallipoli P; Müller-Tidow C; Osborne CS; Vassiliou GS; Huntly BJP
Nat Genet; 2021 Oct; 53(10):1443-1455. PubMed ID: 34556857
[TBL] [Abstract][Full Text] [Related]
32. Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia.
Kornblau SM; Singh N; Qiu Y; Chen W; Zhang N; Coombes KR
Clin Cancer Res; 2010 Mar; 16(6):1865-74. PubMed ID: 20215543
[TBL] [Abstract][Full Text] [Related]
33. Clinical and functional significance of circular RNAs in cytogenetically normal AML.
Papaioannou D; Volinia S; Nicolet D; Świerniak M; Petri A; Mrózek K; Bill M; Pepe F; Walker CJ; Walker AE; Carroll AJ; Kohlschmidt J; Eisfeld AK; Powell BL; Uy GL; Kolitz JE; Wang ES; Kauppinen S; Dorrance A; Stone RM; Byrd JC; Bloomfield CD; Garzon R
Blood Adv; 2020 Jan; 4(2):239-251. PubMed ID: 31945158
[TBL] [Abstract][Full Text] [Related]
34. Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis.
Koren-Michowitz M; Sato-Otsubo A; Nagler A; Haferlach T; Ogawa S; Koeffler HP
Leuk Res; 2012 Apr; 36(4):467-73. PubMed ID: 22071139
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia.
Row C; Lechevalier N; Vial JP; Mimoun A; Bastie JN; Lafon I; Pigneux A; Leguay T; Callanan M; Maynadie M; Béné MC; Dumas PY; Guy J
EJHaem; 2024 Feb; 5(1):84-92. PubMed ID: 38406512
[TBL] [Abstract][Full Text] [Related]
36. Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
Bhatnagar B; Kohlschmidt J; Orwick SJ; Buelow DR; Fobare S; Oakes CC; Kolitz JE; Uy G; Stock W; Powell BL; Nicolet D; Hertlein EK; Mrózek K; Blachly JS; Eisfeld AK; Baker SD; Byrd JC
Blood Adv; 2023 Aug; 7(16):4671-4675. PubMed ID: 37603350
[No Abstract] [Full Text] [Related]
37. Immune checkpoint-related gene polymorphisms are associated with acute myeloid leukemia.
Wu Y; Li M; Meng G; Ma Y; Ye J; Sun T; Ji C
Cancer Med; 2023 Sep; 12(18):18588-18596. PubMed ID: 37602517
[TBL] [Abstract][Full Text] [Related]
38. Alternative polyadenylation quantitative trait loci contribute to acute myeloid leukemia risk genes regulation.
Hu X; Cao P; Wang F; Wang T; Duan J; Chen X; Ma X; Zhang Y; Chen J; Liu H; Zhang H; Wu X
Leuk Res; 2024 Jun; 141():107499. PubMed ID: 38640632
[TBL] [Abstract][Full Text] [Related]
39. DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
Hubner SE; de Camargo Magalhães ES; Hoff FW; Brown BD; Qiu Y; Horton TM; Kornblau SM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982970
[TBL] [Abstract][Full Text] [Related]
40. High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Marquis M; Beaubois C; Lavallée VP; Abrahamowicz M; Danieli C; Lemieux S; Ahmad I; Wei A; Ting SB; Fleming S; Schwarer A; Grimwade D; Grey W; Hills RK; Vyas P; Russell N; Sauvageau G; Hébert J
Blood Cancer J; 2018 Jul; 8(8):68. PubMed ID: 30061630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
